Clinical trial

Prostate Cancer Intensive, Non-Cross Reactive Therapy (PRINT) for Castration Resistant Prostate Cancer (CRPC)

NCT02903160

Study summary

ClinicalTrials.gov

Prostate Cancer Intensive, Non-Cross Reactive Therapy (PRINT) for Castration Resistant Prostate Cancer (CRPC)

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

6 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Mapped RxNorm record Abiraterone acetate Normalized identity: abiraterone acetate View linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Prednisone Normalized identity: prednisone View linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Radium-223 dichloride Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record cabazitaxel Normalized identity: cabazitaxel View linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Carboplatin Normalized identity: carboplatin View linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Enzalutamide Normalized identity: enzalutamide View linked drug · Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2017-01-13

PhasePHASE2

Conditions

Prostate Cancerverified · MONDO: prostate cancer

Interventions

Abiraterone acetateDRUG · verified · RxNorm: abiraterone acetate

PrednisoneDRUG · verified · RxNorm: prednisone

Radium-223 dichlorideDRUG

cabazitaxelDRUG · verified · RxNorm: cabazitaxel

CarboplatinDRUG · verified · RxNorm: carboplatin

EnzalutamideDRUG · verified · RxNorm: enzalutamide

Sponsors & collaborators

Icahn School of Medicine at Mount Sinailead sponsor

Sanoficollaborator

Bayercollaborator

Mapped research locations

New YorkNew York, United States2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02903160 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.